source · application/json
source_c716788aed0c449a
sha256 3338a5fda020557877967e45cc0d5c89789b52b6ce5f0a745a4d0ad2f5240ea2
by researka:v2 · 2026-07-16 06:59:12.825073+04:00
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "f1b39b71-2cc3-43a3-ab5a-287574699c7d", "sources": [{"directness": "primary", "doi": "10.1186/s12885-023-10631-w", "risk_of_bias": "not appraised in public sidecar", "study": "Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer"}, {"directness": "review-level", "doi": "10.1016/j.athplu.2024.10.001", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials"}, {"directness": "primary", "doi": "10.1016/j.eclinm.2026.103798", "risk_of_bias": "not appraised in public sidecar", "study": "Reno-protective effects of statins among patients with chronic kidney disease in Hong Kong: a target trial emulation"}, {"directness": "primary", "doi": "10.12997/jla.2020.9.2.283", "risk_of_bias": "not appraised in public sidecar", "study": "Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin"}, {"directness": "primary", "doi": "10.1016/j.ibneur.2024.07.002", "risk_of_bias": "not appraised in public sidecar", "study": "Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer’s patients: A double-blind placebo-controlled randomized clinical trial"}, {"directness": "primary", "doi": "10.1371/journal.pone.0286670", "risk_of_bias": "not appraised in public sidecar", "study": "Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study"}, {"directness": "primary", "doi": "10.1371/journal.pone.0278282", "risk_of_bias": "not appraised in public sidecar", "study": "The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial"}, {"directness": "primary", "doi": "10.5114/amsad/178441", "risk_of_bias": "not appraised in public sidecar", "study": "The effect of rosuvastatin alone or in combination with fenofibrate or omega-3 fatty acids on lipoprotein(a) levels in patients with mixed hyperlipidemia"}, {"directness": "primary", "doi": "10.3389/fphys.2021.750872", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Evolocumab Added to Moderate-Intensity Statin Therapy in Chinese Patients With Acute Coronary Syndrome: The EMSIACS Trial Study Protocol"}, {"directness": "primary", "doi": "10.1371/journal.pone.0311724", "risk_of_bias": "not appraised in public sidecar", "study": "Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention"}, {"directness": "review-level", "doi": "10.3389/fmed.2021.769740", "risk_of_bias": "not appraised in public sidecar", "study": "Influence of Statin Therapy on the Incidence of Cardiovascular Events, Cancer, and All-Cause Mortality in People Living With HIV: A Meta-Analysis"}, {"directness": "primary", "doi": "10.1177/21501319261453019", "risk_of_bias": "not appraised in public sidecar", "study": "Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients – A Register Study in Finland before COVID-19 Vaccines"}, {"directness": "review-level", "doi": "10.1161/circ.146.suppl_1.12870", "risk_of_bias": "not appraised in public sidecar", "study": "Abstract 12870: Absence of LDL Measurement in Secondary Prevention is Associated With Increased Subsequent Major Adverse Clinical Event (MACE) That is Only Partially Mitigated by Statin Use"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population"}, {"directness": "review-level", "doi": "10.1101/2024.12.13.24318985", "risk_of_bias": "not appraised in public sidecar", "study": "APOEGenotype and Statin Response: Evidence from Electronic Health Records in the UK Biobank and All of Us Research Program"}, {"directness": "review-level", "doi": "10.1101/2025.01.23.25321011", "risk_of_bias": "not appraised in public sidecar", "study": "Understanding the causes and consequences of low statin adherence: evidence from UK Biobank primary care data"}, {"directness": "review-level", "doi": "10.1182/blood-2025-1309", "risk_of_bias": "not appraised in public sidecar", "study": "HMG-CoA reductase inhibitors and the attenuation of risk for disseminated intravascular coagulation in patients with sepsis: Secondary analysis finds no change in the index outcome based on reason for statin prescription"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Estimating prevalence and characteristics of statin intolerance among high and very high cardiovascular risk patients in Germany between 2017–2020"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Simvastatin Withdrawal on Ocular Endothelial Function"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "STATIC - Statin Termination in Cancer"}, {"directness": "review-level", "doi": "10.1101/2024.12.13.24318982", "risk_of_bias": "not appraised in public sidecar", "study": "APOE Genotype and Statin Response: Evidence from the UK Biobank Baseline Assessment and Linked Mortality Data"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL"}, {"directness": "review-level", "doi": "10.1101/2025.09.30.25337016", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of statin treatment on primary and hospital care use: a microsimulation model"}, {"directness": "primary", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin Monotherapy or Statins in Combination With Ezetimibe in Patients for Prevention of CVD"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "The Effects of Rosuvastatin on Running Training Adaptation and Safety"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance"}, {"directness": "primary", "doi": "10.1101/2025.02.24.25321974", "risk_of_bias": "not appraised in public sidecar", "study": "A randomised clinical trial of STAtin therapy for Reducing Events in the Elderly (STAREE): Statistical analysis plan"}, {"directness": "review-level", "doi": "10.1101/2025.10.09.25337698", "risk_of_bias": "not appraised in public sidecar", "study": "Clinical validation of a statin-benefit polygenic score using real-world cohorts of primary prevention participants"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin Reminders for Improving Prescribing in Primary Care"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Atorvastatin in Graves' Orbitopathy (GO)"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Pravastatin to Prevent Preeclampsia"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study"}, {"directness": "primary", "doi": "10.1186/s12877-019-1361-2", "risk_of_bias": "not appraised in public sidecar", "study": "A prospective study of hepatic safety of statins used in very elderly patients"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statins Against Bushfire Smoke"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "MUscle Side-Effects of Atorvastatin in Coronary Patients"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Evaluation of Rosuvastatin Effect as Adjuvant Therapy to Methotrexate on Lipid Profile and the Possibility of its Cardioprotective Effect in Iraqi Patients with Active Rheumatoid Arthritis"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Simvastatin Addition for Patients With Recent-onset Schizophrenia"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Does Rosuvastatin Delay Progression of Atherosclerosis in HIV"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Atorvastatin 2025"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Statin for Elderly 2023"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Evolocumab Plus Ezetimibe 2020"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "TRIal of STatin Therapy n.d."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Multicenter Study to Evaluate 2023"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and Safety of Early 2026"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Estimating Prevalence and Characteristics 2022"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statins Against Bushfire n.d."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Relationship between Insulin Resistance 2020"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin Therapy with Atorvastatin n.d."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Week Phase Study 2017"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Simvastatin Withdrawal 2020"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "MUscle Side-Effects of Atorvastatin 2019"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin TReatment for COVID 2025"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "PCOS 2017"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Envafolimab with Chemotherapy and Simvastatin 2026"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Evaluation of Rosuvastatin Effect 2017"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Randomized Comparison of Efficacy 2026"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "STATIC Statin Termination 2026"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Atorvastatin for Reduction of Day 2021"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Changes in Plaque Characteristics 2026"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Pravastatin in the Subjects 2017"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Evaluate the Efficacy and Safety 2026"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "MACE 2026"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Rosuvastatin for Prevention of Anthracycline-induced n.d."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Simvastatin Addition for Patients 2019"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin Monotherapy or Statins 2021"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "APICES n.d."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Carvedilol Simvastatin vs Carvedilol n.d."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Comparison of Pitavastatin Plus n.d."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Does Rosuvastatin Delay 2018"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Atorvastatin in Graves' 2021"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Intermediate-dose vs Standard Prophylactic 2021"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Moderate-intensity Statin vs Individualized n.d."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Pravastatin Intervention to Delay 2018"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Pravastatin to Prevent Preeclampsia 2021"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin Monotherapy for Treatment 2022"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Statin Reminders for Improving 2024"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "StAtins for Venous Event 2020"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Rosuvastatin on Running 2026"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Ursodeoxycholic Acid Attenuates 2026"}]}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "f1b39b71-2cc3-43a3-ab5a-287574699c7d",
"researka_submission_id": "7c330c3f-54b5-4c2a-b35b-92a340d75e52",
"sidecar_name": "risk_of_bias.json",
"sidecar_url": "https://api.researka.org/publications/f1b39b71-2cc3-43a3-ab5a-287574699c7d/sidecars/risk_of_bias.json"
}